Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne M. Griffiths is active.

Publication


Featured researches published by Anne M. Griffiths.


Science | 2006

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Richard H. Duerr; Kent D. Taylor; Steven R. Brant; John D. Rioux; Mark S. Silverberg; Mark J. Daly; A. Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne M. Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan R. Targan; Lisa W. Datta; Emily O. Kistner; L. Philip Schumm; Annette Lee; Peter K. Gregersen; M. Michael Barmada; Jerome I. Rotter; Dan L. Nicolae; Judy H. Cho

The inflammatory bowel diseases Crohns disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohns disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c.1142G>A, p.Arg381Gln) confers strong protection against Crohns disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohns disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease.


Nature Genetics | 2008

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

Jeffrey C. Barrett; Sarah Hansoul; Dan L. Nicolae; Judy H. Cho; Richard H. Duerr; John D. Rioux; Steven R. Brant; Mark S. Silverberg; Kent D. Taylor; M. Michael Barmada; Alain Bitton; Themistocles Dassopoulos; Lisa W. Datta; Todd Green; Anne M. Griffiths; Emily O. Kistner; Miguel Regueiro; Jerome I. Rotter; L. Philip Schumm; A. Hillary Steinhart; Stephan R. Targan; Ramnik J. Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens

Several risk factors for Crohns disease have been identified in recent genome-wide association studies. To advance gene discovery further, we combined data from three studies on Crohns disease (a total of 3,230 cases and 4,829 controls) and carried out replication in 3,664 independent cases with a mixture of population-based and family-based controls. The results strongly confirm 11 previously reported loci and provide genome-wide significant evidence for 21 additional loci, including the regions containing STAT3, JAK2, ICOSLG, CDKAL1 and ITLN1. The expanded molecular understanding of the basis of this disease offers promise for informed therapeutic development.


Nature Genetics | 2010

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Andre Franke; Dermot McGovern; Jeffrey C. Barrett; Kai Wang; Graham L. Radford-Smith; Tariq Ahmad; Charlie W. Lees; Tobias Balschun; James C. Lee; Rebecca L. Roberts; Carl A. Anderson; Joshua C. Bis; Suzanne Bumpstead; David Ellinghaus; Eleonora M. Festen; Michel Georges; Todd Green; Talin Haritunians; Luke Jostins; Anna Latiano; Christopher G. Mathew; Grant W. Montgomery; Natalie J. Prescott; Soumya Raychaudhuri; Jerome I. Rotter; Philip Schumm; Yashoda Sharma; Lisa A. Simms; Kent D. Taylor; David C. Whiteman

We undertook a meta-analysis of six Crohns disease genome-wide association studies (GWAS) comprising 6,333 affected individuals (cases) and 15,056 controls and followed up the top association signals in 15,694 cases, 14,026 controls and 414 parent-offspring trios. We identified 30 new susceptibility loci meeting genome-wide significance (P < 5 × 10−8). A series of in silico analyses highlighted particular genes within these loci and, together with manual curation, implicated functionally interesting candidate genes including SMAD3, ERAP2, IL10, IL2RA, TYK2, FUT2, DNMT3A, DENND1B, BACH2 and TAGAP. Combined with previously confirmed loci, these results identify 71 distinct loci with genome-wide significant evidence for association with Crohns disease.


Nature Genetics | 2007

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

John D. Rioux; Ramnik J. Xavier; Kent D. Taylor; Mark S. Silverberg; Philippe Goyette; Alan Huett; Todd Green; Petric Kuballa; M. Michael Barmada; Lisa W. Datta; Yin Yao Shugart; Anne M. Griffiths; Stephan R. Targan; Andrew Ippoliti; Edmond Jean Bernard; Ling Mei; Dan L. Nicolae; Miguel Regueiro; L. Philip Schumm; A. Hillary Steinhart; Jerome I. Rotter; Richard H. Duerr; Judy H. Cho; Mark J. Daly; Steven R. Brant

We present a genome-wide association study of ileal Crohn disease and two independent replication studies that identify several new regions of association to Crohn disease. Specifically, in addition to the previously established CARD15 and IL23R associations, we identified strong and significantly replicated associations (combined P < 10−10) with an intergenic region on 10q21.1 and a coding variant in ATG16L1, the latter of which was also recently reported by another group. We also report strong associations with independent replication to variation in the genomic regions encoding PHOX2B, NCF4 and a predicted gene on 16q24.1 (FAM92B). Finally, we demonstrate that ATG16L1 is expressed in intestinal epithelial cell lines and that functional knockdown of this gene abrogates autophagy of Salmonella typhimurium. Together, these findings suggest that autophagy and host cell responses to intracellular microbes are involved in the pathogenesis of Crohn disease.


Nature Genetics | 2001

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

John D. Rioux; Mark J. Daly; Mark S. Silverberg; Kerstin Lindblad; Hillary Steinhart; Zane Cohen; Terrye A. Delmonte; Kerry Kocher; Katie Miller; Sheila Guschwan; Edward J. Kulbokas; Sinéad B. O'Leary; Ellen Winchester; Ken Dewar; Todd Green; Valerie Stone; Christine Chow; Albert Cohen; Diane Langelier; Gilles Lapointe; Daniel Gaudet; Janet Faith; Nancy Branco; Shelley B. Bull; Robin S. McLeod; Anne M. Griffiths; Alain Bitton; Gordon R. Greenberg; Eric S. Lander; Katherine A. Siminovitch

Linkage disequilibrium (LD) mapping provides a powerful method for fine-structure localization of rare disease genes, but has not yet been widely applied to common disease. We sought to design a systematic approach for LD mapping and apply it to the localization of a gene (IBD5) conferring susceptibility to Crohn disease. The key issues are: (i) to detect a significant LD signal (ii) to rigorously bound the critical region and (iii) to identify the causal genetic variant within this region. We previously mapped the IBD5 locus to a large region spanning 18 cM of chromosome 5q31 (P<10−4). Using dense genetic maps of microsatellite markers and single-nucleotide polymorphisms (SNPs) across the entire region, we found strong evidence of LD. We bound the region to a common haplotype spanning 250 kb that shows strong association with the disease (P<2×10−7) and contains the cytokine gene cluster. This finding provides overwhelming evidence that a specific common haplotype of the cytokine region in 5q31 confers susceptibility to Crohn disease. However, genetic evidence alone is not sufficient to identify the causal mutation within this region, as strong LD across the region results in multiple SNPs having equivalent genetic evidence—each consistent with the expected properties of the IBD5 locus. These results have important implications for Crohn disease in particular and LD mapping in general.


Nature Genetics | 2004

Functional variants of OCTN cation transporter genes are associated with Crohn disease

Vanya Peltekova; Richard F. Wintle; Laurence A. Rubin; Christopher I. Amos; Qiqing Huang; Xiangjun Gu; Bill Newman; Mark Van Oene; David W. Cescon; Gordon R. Greenberg; Anne M. Griffiths; Peter St George-Hyslop; Katherine A. Siminovitch

Crohn disease is a chronic, inflammatory disease of the gastrointestinal tract. A locus of ∼250 kb at 5q31 (IBD5) was previously associated with susceptibility to Crohn disease, as indicated by increased prevalence of a risk haplotype of 11 single-nucleotide polymorphisms among individuals with Crohn disease, but the pathogenic lesion in the region has not yet been identified. We report here that two variants in the organic cation transporter cluster at 5q31 (a missense substitution in SLC22A4 and a G→C transversion in the SLC22A5 promoter) form a haplotype associated with susceptibility to Crohn disease. These variants alter transcription and transporter functions of the organic cation transporters and interact with variants in another gene associated with Crohn disease, CARD15, to increase risk of Crohn disease. These results suggest that SLC22A4, SLC22A5 and CARD15 act in a common pathogenic pathway to cause Crohn disease.


Inflammatory Bowel Diseases | 2011

Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification†‡

Arie Levine; Anne M. Griffiths; James Markowitz; David C. Wilson; Dan Turner; Richard K. Russell; John Fell; Frank M. Ruemmele; Thomas D. Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams

Background: Crohns disease and ulcerative colitis are complex disorders with some shared and many unique predisposing genes. Accurate phenotype classification is essential in determining the utility of genotype‐phenotype correlation. The Montreal Classification of IBD has several weaknesses with respect to classification of children. The dynamic features of pediatric disease phenotype (change in disease location and behavior over time, growth failure) are not sufficiently captured by the current Montreal Classification. Methods: Focusing on facilitating research in pediatric inflammatory bowel disease (IBD), and creating uniform standards for defining IBD phenotypes, an international group of pediatric IBD experts met in Paris, France to develop evidence‐based consensus recommendations for a pediatric modification of the Montreal criteria. Results: Important modifications developed include classifying age at diagnosis as A1a (0 to <10 years), A1b (10 to <17 years), A2 (17 to 40 years), and A3 (>40 years), distinguishing disease above the distal ileum as L4a (proximal to ligament of Treitz) and L4b (ligament of Treitz to above distal ileum), allowing both stenosing and penetrating disease to be classified in the same patient (B2B3), denoting the presence of growth failure in the patient at any time as G1 versus G0 (never growth failure), adding E4 to denote extent of ulcerative colitis that is proximal to the hepatic flexure, and denoting ever severe ulcerative colitis during disease course by S1. Conclusions: These modifications are termed the Paris Classification. By adhering to the Montreal framework, we have not jeopardized or altered the ability to use this classification for adult onset disease or by adult gastroenterologists. (Inflamm Bowel Dis 2011)


American Journal of Human Genetics | 2000

Genomewide Search in Canadian Families with Inflammatory Bowel Disease Reveals Two Novel Susceptibility Loci

John D. Rioux; Mark S. Silverberg; Mark J. Daly; A. Hillary Steinhart; Robin S. McLeod; Anne M. Griffiths; Todd Green; Thomas Brettin; Valerie Stone; Shelley B. Bull; Alain Bitton; C. Noel Williams; Gordon R. Greenberg; Zane Cohen; Eric S. Lander; Thomas J. Hudson; Katherine A. Siminovitch

The chronic inflammatory bowel diseases (IBDs)-Crohn disease (CD) and ulcerative colitis (UC)-are idiopathic, inflammatory disorders of the gastrointestinal tract. These conditions have a peak incidence in early adulthood and a combined prevalence of approximately 100-200/100,000. Although the etiology of IBD is multifactorial, a significant genetic contribution to disease susceptibility is implied by epidemiological data revealing a sibling risk of approximately 35-fold for CD and approximately 15-fold for UC. To elucidate the genetic basis for these disorders, we undertook a genomewide scan in 158 Canadian sib-pair families and identified three regions of suggestive linkage (3p, 5q31-33, and 6p) and one region of significant linkage to 19p13 (LOD score 4.6). Higher-density mapping in the 5q31-q33 region revealed a locus of genomewide significance (LOD score 3.9) that contributes to CD susceptibility in families with early-onset disease. Both of these genomic regions contain numerous genes that are important to the immune and inflammatory systems and that provide good targets for future candidate-gene studies.


Inflammatory Bowel Diseases | 2011

Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

Eric I. Benchimol; Kyle J. Fortinsky; Peter Gozdyra; Meta van den Heuvel; Johan Van Limbergen; Anne M. Griffiths

Background: Temporal trends in the incidence of pediatric‐onset inflammatory bowel disease (IBD) are controversial and a wide range of estimates have been reported worldwide. We conducted a systematic review of research describing the epidemiology of childhood‐onset IBD to assess changes in incidence rates over time and to evaluate international differences. Methods: The following electronic databases were searched for articles published 1950–2009: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane IBD/Functional Bowel Disorders Group Specialised Trial Register. All included studies reported incidence or prevalence of IBD, Crohns disease (CD) or ulcerative colitis (UC). Two authors independently completed the data extraction form for each eligible study. Choropleth maps demonstrated the international incidence of IBD, CD, and UC. Incidence of CD and UC was graphed using data from studies reporting rates in multiple time periods. Results: The search yielded 2209 references and review resulted in 139 included studies from 32 countries. A wide range of incidence was reported internationally; however, rates of IBD were not described in most countries. Twenty‐eight studies (20.1%) used statistical analysis to assess trends over time, and 77.8% reported statistically significantly increased incidence of pediatric IBD. Of studies calculating statistical trends in CD incidence, 60% reported significantly increased incidence. Of similar UC studies, 20% reported significantly increased incidence. Conclusions: Globally rising rates of pediatric IBD (due primarily to the rising incidence of CD) was demonstrated in both developed and developing nations; however, most countries lack accurate estimates. Analyzing incidence trends may help identify specific environmental and genetic risk factors for pediatric IBD. (Inflamm Bowel Dis 2011;)


Nature Genetics | 2009

Common variants at five new loci associated with early-onset inflammatory bowel disease

Marcin Imielinski; Robert N. Baldassano; Anne M. Griffiths; Richard K. Russell; Vito Annese; Marla Dubinsky; Subra Kugathasan; Jonathan P. Bradfield; Thomas D. Walters; Patrick Sleiman; Cecilia E. Kim; Aleixo M. Muise; Kai Wang; Joseph T. Glessner; Shehzad A. Saeed; Haitao Zhang; Edward C. Frackelton; Cuiping Hou; James H. Flory; George Otieno; Rosetta M. Chiavacci; Robert W. Grundmeier; M. Castro; Anna Latiano; Bruno Dallapiccola; Joanne M. Stempak; Debra J. Abrams; Kent D. Taylor; Dermot McGovern; Melvin B. Heyman

The inflammatory bowel diseases (IBD) Crohns disease and ulcerative colitis are common causes of morbidity in children and young adults in the western world. Here we report the results of a genome-wide association study in early-onset IBD involving 3,426 affected individuals and 11,963 genetically matched controls recruited through international collaborations in Europe and North America, thereby extending the results from a previous study of 1,011 individuals with early-onset IBD. We have identified five new regions associated with early-onset IBD susceptibility, including 16p11 near the cytokine gene IL27 (rs8049439, P = 2.41 × 10−9), 22q12 (rs2412973, P = 1.55 × 10−9), 10q22 (rs1250550, P = 5.63 × 10−9), 2q37 (rs4676410, P = 3.64 × 10−8) and 19q13.11 (rs10500264, P = 4.26 × 10−10). Our scan also detected associations at 23 of 32 loci previously implicated in adult-onset Crohns disease and at 8 of 17 loci implicated in adult-onset ulcerative colitis, highlighting the close pathogenetic relationship between early- and adult-onset IBD.

Collaboration


Dive into the Anne M. Griffiths's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David R. Mack

Children's Hospital of Eastern Ontario

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James Markowitz

North Shore-LIJ Health System

View shared research outputs
Top Co-Authors

Avatar

Joel R. Rosh

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert N. Baldassano

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wallace Crandall

Nationwide Children's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge